Skip to main content
logo
GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
67.25
+1.01 (1.52%)
Apr 24, 2026, 11:44 AM EDT - Market open

GeneDx Holdings Revenue

In the year 2025, GeneDx Holdings had annual revenue of $427.54M with 39.97% growth. GeneDx Holdings had revenue of $120.99M in the quarter ending December 31, 2025, with 26.50% growth.

Revenue (ttm)
$427.54M
Revenue Growth
+39.97%
P/S Ratio
4.57
Revenue / Employee
$328,876
Employees
1,300
Market Cap
1.97B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025427.54M122.09M39.97%
Dec 31, 2024305.45M102.88M50.79%
Dec 31, 2023202.57M-32.13M-13.69%
Dec 31, 2022234.69M22.50M10.60%
Dec 31, 2021212.20M32.87M18.33%
Dec 31, 2020179.32M-16.85M-8.59%
Dec 31, 2019196.17M62.83M47.12%
Dec 31, 2018133.34M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
RadNet2.04B
Sotera Health Company1.16B
NeoGenomics727.33M
OPKO Health606.88M
Veracyte517.15M
Twist Bioscience391.56M
CareDx379.81M
Castle Biosciences344.23M
Revenue Rankings

WGS News

More News